91 related articles for article (PubMed ID: 15793636)
1. Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis.
Hibi K; Kodera Y; Ito K; Akiyama S; Nakao A
Dis Colon Rectum; 2005 Jun; 48(6):1282-6. PubMed ID: 15793636
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer.
Hibi K; Nakao A
Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679
[TBL] [Abstract][Full Text] [Related]
3. Highly-methylated colorectal cancers show poorly-differentiated phenotype.
Hibi K; Nakao A
Anticancer Res; 2006; 26(6B):4263-6. PubMed ID: 17201142
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation is frequently observed in advanced esophageal squamous cell carcinoma.
Fukuoka T; Hibi K; Nakao A
Anticancer Res; 2006; 26(5A):3333-5. PubMed ID: 17094449
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients.
Fujitake S; Hibi K; Okochi O; Kodera Y; Ito K; Akiyama S; Nakao A
J Gastroenterol; 2004; 39(2):120-4. PubMed ID: 15074307
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
[TBL] [Abstract][Full Text] [Related]
8. Methylation pattern of HLTF gene in digestive tract cancers.
Hibi K; Nakayama H; Kanyama Y; Kodera Y; Ito K; Akiyama S; Nakao A
Int J Cancer; 2003 Apr; 104(4):433-6. PubMed ID: 12584739
[TBL] [Abstract][Full Text] [Related]
9. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
[TBL] [Abstract][Full Text] [Related]
10. RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer.
Imamura Y; Hibi K; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Anticancer Res; 2005; 25(4):2627-30. PubMed ID: 16080503
[TBL] [Abstract][Full Text] [Related]
11. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract][Full Text] [Related]
12. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
[TBL] [Abstract][Full Text] [Related]
13. CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer.
Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Br J Cancer; 2004 Mar; 90(5):1030-3. PubMed ID: 14997203
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.
Babu S; Kumaraswami V; Nutman TB
Infect Immun; 2005 Jun; 73(6):3394-401. PubMed ID: 15908366
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
16. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer.
Leung WK; To KF; Man EP; Chan MW; Bai AH; Hui AJ; Chan FK; Sung JJ
Am J Gastroenterol; 2005 Oct; 100(10):2274-9. PubMed ID: 16181380
[TBL] [Abstract][Full Text] [Related]
17. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
[TBL] [Abstract][Full Text] [Related]
18. CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer.
Wang Z; Yuan X; Jiao N; Zhu H; Zhang Y; Tong J
Pathol Oncol Res; 2012 Apr; 18(2):263-70. PubMed ID: 21796503
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of methylated free circulating DNA in colorectal cancer.
Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
[TBL] [Abstract][Full Text] [Related]
20. Highly methylated genes in colorectal neoplasia: implications for screening.
Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
